Fig. 1From: The cardio-renal-metabolic connection: a review of the evidenceCardio-metabolic-renal interconnections and therapeutic options. SNS, sympathetic nervous system; RAAS, renin–angiotensin–aldosterone system; NPs, natriuretic peptides; SGLT2i: sodium-glucose cotransporter 2 inhibitors; GLP1- RA: glucagon-like peptide 1 receptor agonistsBack to article page